Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin (Q33588223)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin |
scientific article |
Statements
1 reference
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin (English)
1 reference
Marcus Maurer
1 reference
Petra Staubach
1 reference
Randolf Brehler
1 reference
Janine Gericke
1 reference
Veit J Erpenbeck
1 reference
Andrea Bauer
1 reference
Michael Kangas
1 reference
Joanna Ashton-Chess
1 reference
Philip Jarvis
1 reference
Panayiotis Georgiou
1 reference
Janice Canvin
1 reference
Rainer Hillenbrand
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference